Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases Stage I(CADET I) (P50)

The summary for the Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases Stage I(CADET I) (P50) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases Stage I(CADET I) (P50): Purpose. The purpose of this FOA issued by the NHLBI, National Institutes of Health, is to invite applications for clinical research centers for Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases Stage I (CADET I).The overall goal of the CADET program (Stages I and II) is to accelerate the development of novel agents for the diagnosis and treatment of lung diseases and sleep disordered breathing through the use of rational strategies based on fundamental pathobiologic processes. CADET I provides the opportunity to explore potential target(s) for validation to determine which are amenable for development of mechanism-based modalities for direct clinical application in the prevention, diagnosis, and treatment of pulmonary diseases and sleep disordered breathing. Companion FOAs for Clinical Research Centers (CRCs) and a Data Coordinating Center (DCC) for CADET Stage II (CADET II) will be released at a later date.Both the CRCs and DCC announcements will be open competitions.Centers that have been awarded in CADET I may apply for Clinical Research Centers in CADET II. Mechanism of Support. This FOA will utilize the P50 award mechanism. Funds Available and Anticipated Number of Awards. Contingent upon the availability of funding, the total amount to be awarded for CADET I will be a maximum of $30 million for the total program.It is anticipated that up to 30 awards, under this FOA, will be awarded for CADET I. Budget and Project Period.The total project period for an application submitted in response to this FOA is 2 years.Budgets for direct costs of up to $300,000 per year (exclusive of indirect costs associated with consortia) and a project duration of up to 2 years may be requested for a maximum of $600,000 direct costs over a 2-year project period.Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Federal Grant Title: Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases Stage I(CADET I) (P50)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HL-11-015
Type of Funding: Grant
CFDA Numbers: 93.838
CFDA Descriptions: Lung Diseases Research
Current Application Deadline: May 12, 2010
Original Application Deadline: May 12, 2010
Posted Date: Feb 26, 2010
Creation Date: Feb 26, 2010
Archive Date: Jun 12, 2010
Total Program Funding: $30,000,000
Maximum Federal Grant Award: $300,000
Minimum Federal Grant Award:
Expected Number of Awards: 30
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Management of Asthma in Primary Care - Bioinformatics Center (U24 - Clinical Trial Require...
Management of Asthma in Primary Care - Clinical Center (UG3/UH3 - Clinical Trial Required)
Molecular Atlas of Lung Development Program (LungMAP) Phase 2 - Data Coordinating Center (...
Molecular Atlas of Lung Development Program (LungMAP) Phase 2 - Human Tissue Core (U01- Cl...
Molecular Atlas of Lung Development Program (LungMAP) Phase 2 Research Centers (U01- Clini...
Pathogenesis of Sars Lung Disease: in Vitro Studies and Animal Models
Lung Response to Inhaled Highly Toxic Chemicals
Protein Interactions Governing Membrane Transport in Pulmonary Health and Disease (R01)
More Grants from the National Institutes of Health
Limited Competition: RCMI Research Coordination Network (RRCN) (U54 Clinical Trial Not All...
NLM Information Resource Grants to Reduce Health Disparities (G08 Clinical Trial Not Allow...
Leveraging Electronic Medical Records for Psychiatric Genetic Research (R01 Clinical Trial...
Leveraging Electronic Medical Records for Psychiatric Genetic Research (R01 (Collab) Clini...
Research Network on Telomeres as Sentinels of Environmental Exposures, Psychosocial Stress...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2018 FederalGrants.com